Basal-luminal classifiers, such as PAM50, may predict prostate cancer grade progression risk in men with low- to intermediate-risk prostate cancer who are considering active surveillance.

Lunit (KRX:32813), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 21 studies featuring its AI solutions will be presented at the European Congress of ...